申请人:CENTRE NATIONAL de la RECHERCHE SCIENTIFIQUE
公开号:US20190175549A1
公开(公告)日:2019-06-13
The invention relates to a CXCR4 receptor-binding compound for use for increasing or restoring interferon (IFN) level in an individual, wherein the interferon is a type-I interferon (IFN-I).